MedPath

Verification of the usefulness of soft Micro Pore Filter: S-MPF, a filtration membrane that separates novel rare cells, in the extraction of peripheral blood circulation tumor cells in lung cancer patients

Phase 2
Conditions
ung cancer
Registration Number
JPRN-UMIN000046205
Lead Sponsor
ara Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
25
Inclusion Criteria

Not provided

Exclusion Criteria

1. Active malignant tumors (simultaneous malignant tumors and hesychastic malignancies with a disease-free period of less than 5 years). However, lesions equivalent to Carcinoma in situ (intraepithelial cancer) and intramucosal cancer, which are judged to be cured by topical treatment, are not included in active malignant tumors). 2. Patients with infections requiring systemic treatment, including HIV, HBV, and HCV infections. 3. Without the use of an antipyretic, there is a fever of 38 centi degree or more at axillary temperature within 24 hours before registration. 4. The company is subjected to continuous systemic administration (internal or intravenous) of steroids or other immunosuppressants. A case in which the attending physician judged it to be inappropriate to carry out this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath